The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)
Clinical trial NCT01513551 · COMPLETED
Trial details
- NCT number
- NCT01513551
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-13
- Primary completion
- 2013-02-15
- Enrollment
- 692
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.